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A primary vasoconstrictor effect at nanomolar concentration would be in agreement with its cerebrovascular constrictor effect in vivo. However, a direct vasoconstrictor effect of Mel is difficult to obtain in vitro (8) . Ting et al. (26) suggested that Mel constricts pressurized, cylindrical segments but not arterial rings. We tested whether Mel vasoconstricts perfused, pressurized cylindrical segments of the rat tail artery.
A second aspect of our study involved the intracellular transduction mechanism by which Mel potentiates vasoconstriction. (14) showed Mel potentiated the vasoconstrictor response of the rat tail artery to NE and suggested this could be explained by a postsynaptic mechanism by which Mel lowers production of the vasodilator cAMP. The latter effect, reported by Capsoni et al. (5) , provided evidence that nanomolar concentration of Mel inhibits forskolin-stimulated cAMP in rat circle of Willis arteries.
One way of resolving the above problem is to measure vasomotion and [Ca 2ϩ ] i simultaneously in the same preparation. In our paper, therefore, Mel-induced changes in the [Ca 2ϩ ] i sensitivity of vasoconstriction were evaluated in segments of the rat tail artery loaded with the [Ca 2ϩ ] i -sensitive dye, fura 2.
A final aspect of our study is the use of high KCl and NE as vasoconstrictor agents. Several authors (12) have shown that electromechanical stimulation with high KCl involves low [Ca 2ϩ ] i sensitivity of contraction, whereas the latter is amplified in pharmacomechanical stimulation with NE. Furthermore, we have shown that NE-induced vasoconstriction of the rat tail artery has a substantial [Ca 2ϩ ] i -independent component (20) . Were Mel to act on the latter, then it could be expected that Mel would potentiate NE-induced, but not KCl-induced, changes in [Ca 2ϩ ] i sensitivity of contraction. 
METHODS
The tail arteries of male Wistar rats (8-9 mo, 544 Ϯ 17 g, Iffa Credo, L'Arbresle, France) were dissected between 9 and 10 AM [nadir of the Mel cycle (18) ] and experiments performed between 10 AM and 2 PM. The technique for measurement of vasoconstriction and [Ca 2ϩ ] i mobilization has been previously described (2, 3, 20, 27) . Cannulated segments of the tail artery were perfused with a physiological salt solution (PSS) (mM: 140 NaCl, 5 KCl, 1.5 CaCl 2 , 1 MgCl 2 , 6 glucose, and 10 HEPES; in 100% O 2 ; 7.40 Ϯ 0.01 pH; 37°C; at a rate of 1.5 ml/min) and placed in a spectrofluorometer cuvette (Fluorolog F1 T11, SPEX, Edison, NJ). The endothelium was removed by brief coperfusion of air (27) .
Baseline perfusion pressure (mmHg) and tissue autofluorescence (AF) (excitation 360 nm, emission 510 nm) were measured, and the arterial segment was perfused with a high K ϩ solution (80 mM KCl, 2 min, 3ϫ) followed by NE (10 Ϫ6 M, 2 min). Segments whose vasoconstrictor responses to KCl or NE were Ͻ30 or Ͼ50 mmHg were discarded (6/48 ϭ 10%). This initial vasoconstrictor response to KCl (80 mM) was used to normalize subsequent vasoconstrictor responses. Fura 2 was loaded by perfusing PSS containing fura 2-acetoxymethyl (AM) ester (5 ϫ 10 Ϫ6 M) for 90 min, followed by washout with PSS (20 min); isoemissive fluorescence was measured before and after fura 2 loading to calculate loading efficiency.
Excitation (300 to 400 nm, emission 510 nm) and emission fluorescence spectra (480 to 530 nm, excitation 340 or 380 nm) and absorption (340, 380, and 510 nm) of Mel [10 Ϫ10 to 10 Ϫ4 M in 1% vol/vol ethanol, n ϭ 4] were determined. Mel fluorescence was undetectable at concentrations Ͻ10 Ϫ4 M. At 10 Ϫ4 M fluorescence was 10 times less than that of the fura 2-loaded segment. Absorption was insignificantly low (Ͻ0.02).
Segments were illuminated alternatively (1 s) at excitation wavelengths of 340 and 380 nm (emission 510 nm). Background-corrected (see below) changes in fluorescence at 340 nm were divided by those at 380 nm ͑RЈ 340/380 ). The formula of Grynkiewicz et al. (11) as modified by Scanlon et al. (24) , is often used to calculate [Ca 2ϩ ] i (in nM)
where K d represents the dissociation constant, which is 224 nM in PSS in the absence of proteins (11) . RЈ max is the fluorescence ratio at saturating calcium (4 mM CaCl 2 ) plus the calcium ionophore, ionomycin (10 Ϫ5 M, 5 min); RЈ min is the fluorescence ratio in calcium-free PSS containing EGTA (10 Ϫ2 M) and ionomycin (10 Ϫ5 M, 7 min); ␤Ј was the ratio of FЈ 380 at 0 and saturating calcium concentration. The ratio of RЈ max over RЈ min was used as an indication of the extent of hydrolysis of the fura 2-AM ester in each group. Background fluorescence was measured following perfusion with MnCl 2 (10 Ϫ3 M) and ionomycin (10 Ϫ5 M) for 3 min. The K d for fura 2 may be higher than 224 nM in smooth muscle cytoplasm (13) . For instance, K d can be increased by as much as 300% by adding proteins to the calibration solutions (28) . Therefore, we used the simpler formula to estimate [Ca 2ϩ ] i [in arbitrary units (a.u.)]
Signals for perfusion pressure and fura 2 fluorescence were converted into a digital form at a sampling rate of 1 Hz. In a first experiment, arteries were stimulated six times with NE (10 Ϫ6 M, 2 min, 5 min washout between each stimulation) in the presence or absence of increasing concentrations of Mel (10 Ϫ14 to 10 Ϫ4 M). Time and fura 2 controls followed the same protocol in the absence of Mel but were loaded (n ϭ 6) or not loaded (n ϭ 6) with fura 2. Fura 2 had no effect on the vasoconstrictor response to NE (results not shown).
In a second experiment, noncumulative dose-response curves to KCl (20 to 120 mM) and NE (10 Ϫ7 to 3 ϫ 10 Ϫ5 M) were performed in the presence or absence of Mel (10 Ϫ7 M). In this second experiment dose-response curves to KCl and NE were performed on the same segment and were randomized.
All chemicals were purchased from Sigma Chemical (St. Louis, MO), Calbiochem (San Diego, CA), or Merck (Darm- 
RESULTS
A baseline perfusion pressure of 18 Ϯ 1 mmHg was stable throughout the experiment. Neither ethanol nor Mel had any effect on baseline perfusion pressure (P Ͼ 0.05 for both, Fig. 1 ). Mel potentiated NE-induced (10 Ϫ6 M) contraction in a bell-shaped fashion ( Fig. 2A) . Mel had no effect on NE-evoked 
DISCUSSION
Mel has no effect on baseline or KCl-induced increases in perfusion pressure of the rat tail artery but potentiates vasoconstriction induced by NE. The lack of effect of Mel on baseline perfusion pressure, in our experiment, suggests there may be some threshold pressure below which Mel does not increase perfusion pressure, because Ting et al. (26) showed that Mel decreases lumen diameter in pressurized (60 mmHg) rat tail artery segments. Furthermore, in our experiment, Mel had no effect on the vasoconstrictor response to NE at 3 ϫ 10 Ϫ7 M but potentiated that to 10 Ϫ6 M NE.
Although, there is a consistent effect of Mel on KCl-induced vasoconstriction with a shift to the left in the concentration-response curve, this is not significant and is far less marked than the effect of Mel on NE-induced contraction. For a given [Ca 2ϩ ] i mobilization (⌬[Ca 2ϩ ] i ) of 0.4 a.u. vasoconstriction produced by NE was three times greater than that induced by KCl. This suggests that the potentiating effect of Mel depends on the cellular mechanism of contraction involved.
An explanation is that a substantial component of the vasoconstrictor response to NE comes from intracellular amplifying mechanisms downstream or independent of [Ca 2ϩ ] i mobilization such as [Ca 2ϩ ] i -independent modulation of phosphorylation/dephosphorylation events via diacylglycerol-protein kinase C and other pathways (3, 12, 19, 20, 30) . A minor component of the contraction induced by KCl involves NE release from nerve endings (9) . It is possible that the slight potentiation of KCl-induced vasoconstriction by Mel involves KCl-induced NE release. A final argument is that at higher levels of [Ca 2ϩ ] i mobilization, vasoconstriction does not appear to be related to [Ca 2ϩ ] i mobilization, and at such levels, Mel potentiates NE-induced vasoconstriction but not KCl-induced vasoconstriction. This may be an artifact due to flattening off of the response of [Ca 2ϩ ] i -fura complex, although maximal fluorescence in the presence of KCl or NE was far less than that produced by ionomycin.
In conclusion, we suggest that Mel potentiates the vasoconstrictor response to NE at some event downstream of [Ca 2ϩ ] i mobilization, increasing [Ca 2ϩ ] i sensitivity of constriction. This may be of physiological relevance because the effect occurs at nanomolar Mel concentrations which are attained at the peak of the melatonin circadian rhythm (16) .
